Psevdos et al., Corona Virus Disease-19 (COVID-19) in a Veterans Affairs Hospital at Suffolk County, Long Island, New York, Open Forum Infectious Diseases, doi:10.1093/ofid/ofaa439.721
Retrospective 67 hospitalized patients in the USA showing non-statistically significant unadjusted increased mortality with HCQ. Confounding by indication is likely.Time varying confounding is likely. HCQ became controversial and was suspended during the end of the period studied, therefore HCQ use was likely more frequent toward the beginning of the study period, a time when overall treatment protocols were significantly worse.
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details; no treatment details; substantial confounding by time likely due to declining usage over the early stages of the pandemic when overall treatment protocols improved dramatically; substantial unadjusted confounding by indication likely.
Abstract: Conclusion: Mortality in our HIV COVID-19 population was 18%, significantly
lower than the 33% in COVID-19 patients overall at our institution. 39 patients with
HIV were admitted for confirmed COVID-19 infections, which only amounts to 6.5%
of the DAC population, although it is possible that our patients were admitted to other
facilities for COVID-19. In our patients, compliance, viral suppression, and CD4+
counts did not correlate with outcomes. Although our mortality was significantly
lower than the overall hospital mortality, larger studies are needed to fully evaluate the
mortality relationship and determine the protective effects of antiviral therapy and/or
decreased immune response in HIV patients with COVID-19.
Disclosures: All Authors: No reported disclosures
Table 2: PICU patients: Characteristics, Interventions and pharmacotherapy
526. Clinical Presenting Characteristics of Pediatric COVID-19 Infection in a
Tertiary Care Children’s Hospital in Detroit
Jocelyn Y. Ang, MD1; Nirupama Kannikeswaran, MD2; Basim Asmar, MD1; 1Wayne
State University School of Medicine, Detroit, Michigan; 2Central Michigan University
College of Medicine, Detroit, Michigan
Background: There is limited data regarding the presenting clinical characteristics of COVID-19 in children. Our objective is to describe the clinical presentations
and outcomes of COVID-19 infection early in the pandemic at our institution.
Methods:
We performed a retrospective chart review of children up to
18 years who underwent testing for SARS CoV-2 from March 1st to May 10th 2020
at our pediatric emergency department. We abstracted patient’s demographics,
clinical presentation, diagnostic studies and patient disposition. We classified the
severity of clinical illness based on published criteria. We excluded patients diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C) associated
with COVID-19.
Results: SARS CoV-2 testing was performed on 481 patients of whom 43 (8.9%)
tested positive. Of these, 4 were diagnosed with MIS-C. Data of 39 patients were analyzed. Patients’ demographics, co-morbidities, presenting signs and symptoms and disposition are shown in Table 1. Age range was 47 days – 18 years. Infants representing
one third (14/39; 35.9%) of our study cohort. There was equal sex distribution. Asthma
or obesity was present in 17 (44%). The most common presenting symptoms included
fever, cough, shortness of breath and diarrhea. Chest radiograph showed pneumonia
in 12 (30.8%) patients. Two thirds (27/39; 69.2%) were asymptomatic or had mild
disease; six patients (15.4%) had severe or critical illness (Figure 1). Nineteen (48%)
patients were admitted to the general pediatric service. Eleven (28%) were admitted to
the Intensive Care Units (ICU). The characteristics, presenting symptoms and interventions performed in the PICU cohort are shown in Table 2. Half of these patients
required mechanical ventilation. There was one death in a 3 month old infant unrelated to SARS CoV-2. Majority of the infants required hospitalization (12/14; 85.7%),
including 4 to the PICU (one each for non accidental trauma, ingestion, seizure and
pneumonia).
Table 1. Patient demographics, signs and symptoms of COVID-19 infection in
Children
Figure 1: Severity of Ill ness in the study cohort
Conclusion: Majority (17; 43%) of our children with COVID-19 had a mild disease. Eleven (28%) including 4 infants required critical care; 5 required mechanical
ventilation. There was no COVID-19..
Late treatment is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.